國立虎尾科技大學 |

Aggressive Lymphomas

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Aggressive Lymphomas/ edited by Georg Lenz, Gilles Salles.
其他作者:	Lenz, Georg.
面頁冊數:	VII, 360 p. 70 illus., 65 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Hematology. -
電子資源:	https://doi.org/10.1007/978-3-030-00362-3
ISBN:	9783030003623

Aggressive Lymphomas
Aggressive Lymphomas[electronic resource] /edited by Georg Lenz, Gilles Salles. - 1st ed. 2019. - VII, 360 p. 70 illus., 65 illus. in color.online resource. - Hematologic Malignancies,2197-9766. - Hematologic Malignancies,.

PART I: Epidemiology, Pathology and molecular Pathogenesis: Epidemiology -- Pathology and molecular pathogenesis of DLBCL and related entities -- Pathology and molecular pathogenesis of Burkitt lymphoma and lymphoblastic lymphoma -- Pathology and molecular pathogenesis of T-cell lymphoma -- Part III: Future directions in aggressive lymphomas: Role of modern imaging in aggressive lymphoma -- Kinase inhibitors -- Immunologic approaches -- Other novel targeted therapies -- How biology will help guiding our treatment decisions?.

This book summarizes current knowledge of the biology and molecular pathogenesis of aggressive lymphomas and reviews the state of the art in diagnostic and therapeutic strategies. The aim is both to provide the reader with a sound understanding of the very significant progress that has been achieved in the understanding and management of these malignancies over recent years and to facilitate appropriate choice of the therapeutic strategy in individual cases. The assessment of different prognostic parameters are clearly presented in order to permits effective risk stratification that impacts on treatment choice. Recent insights into lymphomagenesis are exemplified and may assist in identifying emerging therapeutic targets. The comprehensive and up-to-date nature of the book will make it an ideal reference for all physicians and researchers interested in lymphoma, including clinicians from various medical specialties, biologists, pathologists, radiologists and nuclear medicine specialist, as well as students.

ISBN: 9783030003623

Standard No.: 10.1007/978-3-030-00362-3doiSubjects--Topical Terms:

645254
Hematology.

LC Class. No.: RB45

Dewey Class. No.: 616.15

Aggressive Lymphomas
LDR:02862nam a22003975i 4500 001 1010672
003 DE-He213
005 20200704075532.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030003623 $9 978-3-030-00362-3
024 7 $a 10.1007/978-3-030-00362-3 $2 doi
035 $a 978-3-030-00362-3
050 4 $a RB45
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.15 $2 23
245 1 0 $a Aggressive Lymphomas $h [electronic resource] / $c edited by Georg Lenz, Gilles Salles.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a VII, 360 p. 70 illus., 65 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Hematologic Malignancies, $x 2197-9766
505 0 $a PART I: Epidemiology, Pathology and molecular Pathogenesis: Epidemiology -- Pathology and molecular pathogenesis of DLBCL and related entities -- Pathology and molecular pathogenesis of Burkitt lymphoma and lymphoblastic lymphoma -- Pathology and molecular pathogenesis of T-cell lymphoma -- Part III: Future directions in aggressive lymphomas: Role of modern imaging in aggressive lymphoma -- Kinase inhibitors -- Immunologic approaches -- Other novel targeted therapies -- How biology will help guiding our treatment decisions?.
520 $a This book summarizes current knowledge of the biology and molecular pathogenesis of aggressive lymphomas and reviews the state of the art in diagnostic and therapeutic strategies. The aim is both to provide the reader with a sound understanding of the very significant progress that has been achieved in the understanding and management of these malignancies over recent years and to facilitate appropriate choice of the therapeutic strategy in individual cases. The assessment of different prognostic parameters are clearly presented in order to permits effective risk stratification that impacts on treatment choice. Recent insights into lymphomagenesis are exemplified and may assist in identifying emerging therapeutic targets. The comprehensive and up-to-date nature of the book will make it an ideal reference for all physicians and researchers interested in lymphoma, including clinicians from various medical specialties, biologists, pathologists, radiologists and nuclear medicine specialist, as well as students.
650 0 $a Hematology. $3 645254
650 0 $a Pathology. $3 668553
650 0 $a Immunology. $3 592892
700 1 $a Lenz, Georg. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1304764
700 1 $a Salles, Gilles. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1304765
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030003616
776 0 8 $i Printed edition: $z 9783030003630
830 0 $a Hematologic Malignancies, $x 2197-9766 $3 1253495
856 4 0 $u https://doi.org/10.1007/978-3-030-00362-3
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)